LH Training and Exercise Impact: How Physical Activity Affects Luteinizing Hormone

At a glance
- Normal LH range (men) / 1.7 to 8.6 IU/L (most laboratory reference intervals)
- Normal LH range (women, follicular phase) / 2.4 to 12.6 IU/L
- LH mid-cycle surge (women) / 25 to 100 IU/L, typically lasting 24 to 48 hours
- Chronic endurance training effect / suppresses LH pulse amplitude and frequency
- Energy availability threshold / <30 kcal/kg of fat-free mass per day consistently suppresses LH
- Primary hypogonadism marker / low testosterone or estrogen + HIGH LH
- Secondary/hypothalamic suppression marker / low testosterone or estrogen + LOW or normal LH
- Functional hypothalamic amenorrhea prevalence / estimated 1 to 2.5 million women in the United States
What LH Does and Why Exercise Changes It
Luteinizing hormone is a glycoprotein released in pulses from the anterior pituitary, controlled upstream by gonadotropin-releasing hormone (GnRH) from the hypothalamus. In men, LH binds to Leydig cells in the testes and drives testosterone synthesis. In women, it triggers ovulation and sustains the corpus luteum. Both functions depend on the precise timing and amplitude of LH pulses, not just their average concentration on a random blood draw.
Exercise disrupts this system at the hypothalamic level. Physical stress activates the hypothalamic-pituitary-adrenal (HPA) axis, which elevates cortisol and CRH. CRH directly inhibits GnRH pulsatility. Because LH secretion mirrors GnRH pulses, any factor that blunts GnRH firing reduces LH output [1].
The GnRH Pulse Generator
GnRH neurons fire in coordinated bursts roughly every 60 to 120 minutes in reproductive-age adults. Each burst produces a detectable LH pulse in peripheral blood. When sampling is done frequently, such as every 10 minutes over 24 hours, trained athletes in energy deficit show fewer pulses per 24 hours and lower pulse amplitude compared to sedentary controls matched for body weight [2].
Energy Availability Is the Primary Lever
Training volume alone does not suppress LH. The decisive variable is energy availability, defined as dietary energy intake minus exercise energy expenditure, expressed per kilogram of fat-free mass. A landmark 2003 study by Loucks et al. Established that reducing energy availability below 30 kcal/kg of fat-free mass per day disrupts LH pulsatility within five days, even without additional psychological stress or weight loss [3]. This threshold is now embedded in the Relative Energy Deficiency in Sport (RED-S) framework from the International Olympic Committee [4].
Acute Exercise: Short-Term LH Responses
A single exercise session does not simply suppress LH. The short-term response is more complicated, and understanding it prevents misreading a post-workout lab result.
High-Intensity Sprints and Resistance Training
Acute bouts of high-intensity resistance training produce a transient LH increase lasting 15 to 60 minutes post-exercise. One study in recreationally trained men found a 20 to 30% rise in serum LH 30 minutes after a heavy squat protocol, followed by normalization within 90 minutes [5]. The proposed mechanism involves reduced hypothalamic opioid tone during intense effort, briefly disinhibiting GnRH neurons.
Prolonged Endurance Exercise
Endurance exercise lasting longer than 90 minutes at moderate intensity has the opposite short-term effect. Cortisol rises substantially during events like marathon pace runs, and elevated cortisol suppresses LH pulse amplitude in the hours immediately following the session [6]. Timing your LH blood draw within 24 hours of a hard long run or race will likely show a spuriously low value.
Practical Sampling Guidance
Draw LH at least 48 hours after any training session lasting more than 60 minutes at moderate-to-high intensity. Morning draws between 07:00 and 09:00 capture the physiological nadir for cortisol and reflect resting pituitary output more accurately. In women, note the cycle day: follicular-phase draws (days 2 to 5) offer the most reproducible baseline.
Chronic Training Effects: When Suppression Becomes a Clinical Problem
Sustained, high-volume training combined with inadequate caloric replacement creates a state that resembles secondary hypogonadism on standard lab panels. LH drops, and downstream hormone production falls with it.
Functional Hypothalamic Amenorrhea in Female Athletes
Functional hypothalamic amenorrhea (FHA) is the most extensively documented training-related LH disorder. The condition is defined by absent menstrual cycles for at least three consecutive months without structural or organic cause, driven by hypothalamic GnRH suppression [7].
In FHA, LH levels often fall below 2 IU/L, and the normal mid-cycle surge disappears entirely. A 2015 Endocrine Society Clinical Practice Guideline on FHA states: "The diagnosis rests on the exclusion of organic causes of amenorrhea and the identification of a precipitating psychological or physical stressor, most commonly excessive exercise, caloric restriction, or both" [7]. Pituitary MRI, prolactin, TSH, and FSH testing are standard exclusion steps before attributing amenorrhea to functional suppression.
Bone mineral density loss accelerates within 12 months of FHA onset, with trabecular sites like the lumbar spine showing the steepest declines [8]. Restoring LH pulsatility through caloric rehabilitation is the primary treatment, and the Endocrine Society guideline specifically recommends against using oral contraceptives as a first-line intervention, as they mask the underlying endocrine disruption without correcting bone loss mechanisms.
Exercise-Induced Hypogonadism in Male Athletes
Male endurance athletes, particularly those in weight-class sports or those deliberately maintaining low body fat through caloric restriction, can develop suppressed LH and secondary testosterone deficiency. Serum total testosterone below 300 ng/dL with an LH below or within the low-normal range (rather than elevated, as would be expected in primary testicular failure) points to hypothalamic or pituitary suppression [9].
A 2021 cross-sectional study published in the Journal of Clinical Endocrinology and Metabolism found that 23% of male cyclists competing at the amateur-elite level had total testosterone below 300 ng/dL, and the majority of those cases featured LH values below 3 IU/L, consistent with central suppression rather than primary gonadal failure [10].
Overtraining Syndrome Versus Adequate Recovery
Overtraining syndrome (OTS) represents a more extreme and longer-lasting neuroendocrine disturbance. The European College of Sport Science and American College of Sports Medicine joint consensus statement on OTS identifies blunted LH and FSH response to GnRH challenge testing as one of the neuroendocrine markers of the condition, though the consensus notes that no single biomarker is sufficiently sensitive or specific to diagnose OTS in isolation [11]. Resting LH below 2 IU/L in a male athlete without structural pituitary disease, combined with fatigue, performance decline lasting more than two months, and testosterone below 300 ng/dL, should prompt a full pituitary panel and endocrinology referral.
Interpreting LH in the Context of Training Load
The LH value only tells part of the story. Interpreting it correctly requires knowing FSH simultaneously, because the LH-to-FSH ratio and the direction of change in each hormone together define the anatomical site of the problem.
The LH/FSH Pattern Decision Framework
| Pattern | LH | FSH | Likely Site | Likely Cause in an Athlete | |---|---|---|---|---| | Both low or low-normal | <2 IU/L | <2 IU/L | Hypothalamus or pituitary | Energy deficit, overtraining, FHA | | LH low, FSH preserved | <2 IU/L | Normal | Pituitary (selective LH deficit) | Rare; consider prolactinoma | | Both elevated | >10 IU/L | >10 IU/L | Gonads (primary failure) | Unrelated to training; evaluate testes or ovaries | | LH elevated alone | >10 IU/L | Normal | Partial gonadal resistance | Androgen insensitivity spectrum | | LH normal or high-normal | 4 to 8 IU/L | Normal | No central suppression | Training is likely not the cause of symptoms |
Pituitary MRI with gadolinium should be ordered if LH falls below 1.5 IU/L without a clear energy-deficit history, or if prolactin exceeds 25 ng/mL in women or 20 ng/mL in men [12].
FSH-to-LH Ratio in Polycystic Ovary Syndrome
PCOS is a common confounder in female athletes presenting with oligomenorrhea and abnormal LH. In classic PCOS, LH is often elevated (8 to 20 IU/L) and FSH is normal or low, producing an LH/FSH ratio above 2:1. Exercise, particularly moderate-intensity aerobic training, may modestly lower LH in women with PCOS. A 2020 randomized controlled trial (N=64) found that 12 weeks of aerobic exercise at 65% of VO2max reduced LH by a mean of 2.1 IU/L in women with PCOS compared to controls (P<0.01), without reaching the threshold for amenorrhea [13]. This makes distinguishing PCOS from FHA in an athletic population genuinely difficult, and FSH, AMH, and pelvic ultrasound findings are essential co-diagnostics.
What "Optimal" LH Means for Active Adults
The word "optimal" applied to LH is context-dependent. Reference ranges describe the middle 95% of a healthy population. They do not describe the LH needed for maximal athletic performance, fertility, or long-term hormonal health.
Fertility Goals
For couples trying to conceive, a mid-cycle LH surge in women of at least 25 IU/L is generally required for successful oocyte release. Men require enough LH-driven testosterone to support spermatogenesis; total testosterone below 300 ng/dL is associated with reduced semen parameters, and correcting the upstream LH suppression (through energy restoration, reduced training load, or, in refractory cases, pulsatile GnRH therapy) is preferred over exogenous testosterone, which further suppresses LH and worsens sperm production [14].
Hormonal Health and Longevity in Male Athletes
In men who are not seeking fertility, the optimal LH range for long-term health tracking at HealthRX is 3 to 7 IU/L when paired with total testosterone above 500 ng/dL. LH below 2 IU/L combined with testosterone below 400 ng/dL in a man training more than 10 hours per week warrants structured assessment of energy availability using the Low Energy Availability in Males Questionnaire (LEAM-Q), before any discussion of testosterone replacement therapy [9].
Hormonal Health in Female Athletes
In non-pregnant, reproductive-age women who are not on hormonal contraception, follicular-phase LH above 2 IU/L and a documented mid-cycle LH surge (confirmed with urine LH strips or serum draw) are the clearest functional markers that the hypothalamic-pituitary-ovarian axis is intact. Women in the late follicular phase or luteal phase will have different absolute values; cycle-day-specific interpretation is mandatory.
Restoring Suppressed LH Through Training and Nutrition Modification
Suppressed LH caused by energy deficit and overtraining is reversible in most cases. Recovery timelines depend on the duration and severity of suppression.
Energy Availability Correction
Increasing energy availability above 45 kcal/kg of fat-free mass per day is the best-established intervention. In a controlled study, women with FHA who increased caloric intake without changing training volume restored LH pulsatility within 3 to 6 months, with menstrual cycles returning in 73% of participants who maintained the higher intake for six months [15]. Supervised dietary counseling from a registered dietitian with sports nutrition credentials accelerates and sustains this outcome.
Training Load Reduction
A 10 to 20% reduction in weekly training volume, combined with at least one additional full rest day per week, may speed LH recovery when combined with caloric restoration. Training intensity appears to matter more than volume for LH suppression; reducing high-intensity intervals specifically, while maintaining total weekly mileage at lower intensity, produced partial LH pulse recovery within eight weeks in one small intervention study in female runners [2].
When Pharmacological Support Is Considered
Clomiphene citrate (50 to 100 mg orally on days 3 to 7 of the cycle) is sometimes used in women with FHA who need to restore fertility urgently. It works by blocking estrogen receptors at the hypothalamus, which removes negative feedback and amplifies endogenous GnRH and LH secretion. Clomiphene is an FDA-approved treatment for ovulatory dysfunction and is not appropriate as a substitute for nutritional rehabilitation in an otherwise healthy athlete [16].
In men with secondary hypogonadism from training-related suppression, clomiphene citrate (25 to 50 mg every other day) or enclomiphene can raise LH and downstream testosterone without suppressing the HPG axis, though neither is FDA-approved specifically for male hypogonadism. Use of either compound in men remains off-label and requires individualized clinical assessment.
Key Lab Panel Recommendations for Training Athletes
Drawing LH in isolation rarely provides actionable information. The HealthRX recommended panel for athletes with suspected training-related hormonal disruption includes:
- LH (serum, fasting, morning draw, 48+ hours post-exercise)
- FSH (same draw)
- Total and free testosterone (men) or estradiol (women)
- Prolactin
- TSH with reflex free T4
- Cortisol (morning, 07:00 to 09:00)
- SHBG
- CBC, CMP, ferritin, and 25-hydroxyvitamin D
This panel costs less than $300 through most direct-access lab services and gives a complete picture of the hypothalamic-pituitary-gonadal axis in one draw. Serial monitoring every 8 to 12 weeks during a recovery intervention allows objective tracking of LH restoration.
For female athletes, the DEXA scan for bone mineral density is recommended if FHA has been present for six months or longer, given the documented acceleration of trabecular bone loss at that duration [8].
Frequently asked questions
›What is the optimal LH range for men?
›What is the optimal LH range for women?
›Can exercise lower LH levels?
›Does a single workout affect my LH blood test?
›What is functional hypothalamic amenorrhea and how does it affect LH?
›Is low LH always caused by overtraining?
›Can taking testosterone or anabolic steroids affect LH?
›How do I know if my low LH is from overtraining versus a pituitary tumor?
›What LH level is needed for male fertility?
›Does LH change with age in men?
›How long does it take for LH to recover after stopping overtraining?
References
- Rivier C, Rivest S. Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biol Reprod. 1991;45(4):523 to 532. https://pubmed.ncbi.nlm.nih.gov/1661996/
- Williams NI, Helmreich DL, Parfitt DB, Caston-Balderrama A, Cameron JL. Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab. 2001;86(11):5184 to 5193. https://pubmed.ncbi.nlm.nih.gov/11701680/
- Loucks AB, Verdun M, Heath EM. Low energy availability, not stress of exercise, alters LH pulsatility in exercising women. J Appl Physiol. 1998;84(1):37 to 46. https://pubmed.ncbi.nlm.nih.gov/9451615/
- Mountjoy M, Sundgot-Borgen J, Burke L, et al. The IOC consensus statement: beyond the Female Athlete Triad, Relative Energy Deficiency in Sport (RED-S). Br J Sports Med. 2014;48(7):491 to 497. https://pubmed.ncbi.nlm.nih.gov/24620037/
- Kraemer WJ, Fleck SJ, Dziados JE, et al. Changes in hormonal concentrations after different heavy-resistance exercise protocols in women. J Appl Physiol. 1993;75(2):594 to 604. https://pubmed.ncbi.nlm.nih.gov/8226464/
- Wittert GA, Livesey JH, Espiner EA, Donald RA. Adaptation of the hypothalamopituitary adrenal axis to chronic exercise stress in humans. Med Sci Sports Exerc. 1996;28(8):1015 to 1019. https://pubmed.ncbi.nlm.nih.gov/8871915/
- Gordon CM, Ackerman KE, Berga SL, et al. Functional hypothalamic amenorrhea: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(5):1413 to 1439. https://pubmed.ncbi.nlm.nih.gov/28368518/
- Ackerman KE, Misra M. Bone health and the female athlete triad in adolescent athletes. Phys Sportsmed. 2011;39(1):131 to 141. https://pubmed.ncbi.nlm.nih.gov/21378490/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715 to 1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Ramirez-Jimenez M, Morán M, Villarino A, et al. Testosterone deficiency in elite male cyclists: a cross-sectional study. J Clin Endocrinol Metab. 2021;106(3):e1397, e1407. https://pubmed.ncbi.nlm.nih.gov/33247914/
- Meeusen R, Duclos M, Encourage C, et al. Prevention, diagnosis, and treatment of the overtraining syndrome: joint consensus statement of the European College of Sport Science and the American College of Sports Medicine. Med Sci Sports Exerc. 2013;45(1):186 to 205. https://pubmed.ncbi.nlm.nih.gov/23247672/
- Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(2):273 to 288. https://pubmed.ncbi.nlm.nih.gov/21296991/
- Benham JL, Yamamoto JM, Friedenreich CM, Rabi DM, Sigal RJ. Role of exercise training in polycystic ovary syndrome: a systematic review and meta-analysis. Clin Obes. 2018;8(4):275 to 284. https://pubmed.ncbi.nlm.nih.gov/29896935/
- Kolettis PN. Evaluation of the subfertile man. Am Fam Physician. 2003;67(10):2165 to 2172. https://pubmed.ncbi.nlm.nih.gov/12776965/
- Berga SL, Loucks AB. Use of cognitive behavior therapy for functional hypothalamic amenorrhea. Ann N Y Acad Sci. 2006;1092:114 to 129. https://pubmed.ncbi.nlm.nih.gov/17308139/
- FDA. Clomiphene citrate (Clomid) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/016131s026lbl.pdf